Clinical Trial Update: NIR-Guided Sentinel Lymph Node Mapping in Melanoma [Phase 1]

View source ↗

Summary

This update reports completion of a Phase 1 trial evaluating near-infrared guided sentinel lymph node mapping in patients with melanoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Melanoma | Phase 1 | Status: COMPLETED